Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A
Clinical trial NCT03700229 · UNKNOWN
Trial details
- NCT number
- NCT03700229
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2019-10-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.